Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1351 to 1400 of 2417

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Everolimus and sunitinib for treating unresectable or metastatic neuroendocrine tumours in people with progressive diseaseTA449
Blinatumomab for previously treated Philadelphia-chromosome-negative acute lymphoblastic leukaemiaTA450
Ponatinib for treating chronic myeloid leukaemia and acute lymphoblastic leukaemiaTA451
Eliglustat for treating type 1 Gaucher diseaseHST5
Infracoccygeal sacropexy using mesh to repair vaginal vault prolapseIPG581
Infracoccygeal sacropexy using mesh to repair uterine prolapseIPG582
Sacrocolpopexy using mesh to repair vaginal vault prolapseIPG583
Uterine suspension using mesh (including sacrohysteropexy) to repair uterine prolapseIPG584
Multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysisDG29
RIDASCREEN tests for monitoring infliximab in inflammatory bowel diseaseMIB109
Neo Pedicle Screw System for spinal fusion surgeryMIB108
Oral health in care homesQS151
SecurAcath for securing cerebrospinal fluid cathetersMIB107
Obesity: working with local communitiesPH42
Spondyloarthritis in over 16s: diagnosis and managementNG65
Haematological cancersQS150
Bindex for investigating suspected osteoporosisMIB106
Afatinib for treating advanced squamous non-small-cell lung cancer after platinum-based chemotherapy (terminated appraisal)TA444
Certolizumab pegol and secukinumab for treating active psoriatic arthritis after inadequate response to DMARDsTA445
Endoscopic full thickness removal of non-lifting colonic polypsIPG580
Idiopathic pulmonary fibrosis in adults: diagnosis and managementCG163
Permacol for treating anal fistulaeMIB105
NaviCam for diagnosing gastrointestinal tract conditionsMIB104
Virtual chromoendoscopy to assess colorectal polyps during colonoscopyDG28
Intravenous fluid therapy in adults in hospitalCG174
Irreversible electroporation for treating pancreatic cancerIPG579
Hemosep for cell salvageMIB103
OsteoporosisQS149
Pegylated liposomal irinotecan for treating pancreatic cancer after gemcitabineTA440
Ixekizumab for treating moderate to severe plaque psoriasisTA442
Obeticholic acid for treating primary biliary cholangitisTA443
VAAFT for treating anal fistulaeMIB102
Antisocial behaviour and conduct disorders in children and young people: recognition and managementCG158
Alcohol-use disorders: diagnosis and management of physical complicationsCG100
Sexually transmitted infections: condom distribution schemesNG68
Minimally invasive sacroiliac joint fusion surgery for chronic sacroiliac painIPG578
Irritable bowel syndrome in adults: diagnosis and managementCG61
Managing medicines for adults receiving social care in the communityNG67
Alectinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer (terminated appraisal)TA438
Panitumumab in combination with chemotherapy for the treatment of metastatic colorectal cancer (terminated appraisal)TA240
Mitochondrial disorders in children: Co-enzyme Q10ES11
Mollii suit for spasticityMIB100
Bair Hugger for measuring core temperature during perioperative careMIB99
Patient group directionsMPG2
Bevacizumab for treating EGFR mutation-positive non-small-cell lung cancer (terminated appraisal)TA436
Ibrutinib with bendamustine and rituximab for treating relapsed or refractory chronic lymphocytic leukaemia after systemic therapy (terminated appraisal)TA437
Elotuzumab for previously treated multiple myeloma (terminated appraisal)TA434
Tenofovir alafenamide for treating chronic hepatitis B (terminated appraisal)TA435
Extraurethral (non-circumferential) retropubic adjustable compression devices for stress urinary incontinence in womenIPG576
Sacrocolpopexy with hysterectomy using mesh to repair uterine prolapseIPG577

Results per page

  1. 10
  2. 25
  3. 50
  4. All